Gonorrhea Treatment Guidelines

Introduction to Treatment

• The Centers for Disease Control and Prevention (CDC) recommends ceftriaxone 500 mg IM as a single dose, plus one of the following: azithromycin 1 g orally in a single dose, or doxycycline 100 mg orally twice daily for 7 days, for the treatment of gonorrhea, with a cure rate of 97.4% for urogenital and anorectal infections 1, 2
• The recommended regimen is ceftriaxone 500 mg IM as a single dose plus azithromycin 1 g orally as a single dose, as supported by the CDC guidelines 1, 2

Diagnosis and Treatment Considerations

• Pharyngeal gonococcal infections are more difficult to eradicate than urogenital infections, and chlamydial co-infection is common in cervicitis but less common in the pharynx 1, 3
• For patients allergic to cephalosporins, consider alternative regimens based on local resistance patterns, such as cefixime 400 mg orally as a single dose or spectinomycin 2 g IM as a single dose for patients with severe beta-lactam allergy 1, 4
• Pregnant patients should not receive doxycycline; instead, azithromycin or amoxicillin should be used, as recommended by the CDC guidelines, with ceftriaxone as the primary treatment 5, 6
• The American Academy of Ophthalmology recommends avoiding tetracyclines (including doxycycline) in pregnancy due to contraindication 7

Pediatric Treatment

• For gonorrhea in children, the American Academy of Pediatrics recommends weight-based dosing for children <45 kg and adult dosing for children >45 kg, with the following recommended dosage table:

2, 8

Partner Notification and Treatment

• All sex partners from the previous 60 days should be evaluated and treated, with partners receiving the same treatment as the index patient, and both patient and partners should abstain from sexual activity until therapy is completed and symptoms have resolved 1, 3
• Inadequate partner notification and treatment is a major cause of reinfection and treatment failure, and patients should avoid sexual activity until therapy is completed and both they and their partners no longer have symptoms, as recommended by the CDC 1, 3, 2, 5

Follow-up and Test of Cure

• Test of cure is not routinely needed for uncomplicated infections treated with recommended regimens, but persistent symptoms warrant culture with antimicrobial susceptibility testing 1, 3
• Complete at least one week of total antimicrobial therapy, even if rapid improvement occurs, and retest approximately 3 months after treatment due to high reinfection rates 1, 5, 2, 9

Treatment of Complicated Infections

• For orchitis requiring intravenous therapy, the CDC recommends ceftriaxone 1 gram IV every 24 hours as the first-line regimen, with additional coverage for chlamydia if not excluded 2
• Alternative regimens for orchitis include cefotaxime 1 g IV every 8 hours, ceftizoxime 1 g IV every 8 hours, ciprofloxacin 400 mg IV every 12 hours, ofloxacin 400 mg IV every 12 hours, and levofloxacin 250-750 mg IV daily 2
• IV therapy should be continued for 24-48 hours after clinical improvement begins, then transitioned to appropriate oral therapy to complete at least 1 week of total antimicrobial therapy, with oral step-down therapy options including cefixime 400 mg orally twice daily, ciprofloxacin 500 mg orally twice daily, ofloxacin 400 mg orally twice daily, and levofloxacin 500 mg orally once daily 2

Antimicrobial Resistance and Treatment

• N. gonorrhoeae has developed resistance to multiple antibiotics, including penicillins, tetracyclines (20.6-21.6% resistance), fluoroquinolones, and macrolides, with decreased susceptibility to cephalosporins emerging globally 5, 9
• The Infectious Diseases Society of America supports the use of levofloxacin 250-750 mg IV daily as an alternative regimen, with a strength of evidence supporting its use 10

Recommended Treatment Regimens

• The following table summarizes the recommended treatment regimens for different conditions:

1, 2